Table 4:
Clinical outcome
Outcome
Parenchymal hematoma type 1 and 2
7.5% (3/40)
Symptomatic hemorrhage
5.3% (2/38)
90-Day mRS available
85% (34/40)
0
2.9% (1/34)
1
17.1% (6/34)
2
5.9% (2/34)
3
5.9% (2/34)
4
0% (0/34)
5
11.8% (4/34)
6
55.9% (19/34)